Coherus Oncology, Inc.

8-K Changed accountants Jun 15, 2026 8-K Shareholder vote results Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release) Mar 9, 2026 8-K Other events Feb 17, 2026 8-K Other events Feb 4, 2026 8-K Other events Jan 23, 2026 8-K Results of operations (earnings release) Jan 13, 2026 8-K Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Delisting notice or listing-rule failure Jul 3, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Amended charter or bylaws; Regulation FD disclosure May 30, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change Apr 25, 2025 8-K Director or officer change Apr 22, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Apr 14, 2025 8-K Entered a material agreement; Other events Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Shareholder vote results Mar 13, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Other events Mar 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Dec 4, 2024 8-K Entered a material agreement; Regulation FD disclosure Dec 3, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Regulation FD disclosure Sep 13, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Director or officer change Aug 8, 2024 8-K Entered a material agreement Jul 2, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Other events Jun 27, 2024 8-K Director or officer change Jun 5, 2024